Atlas Trials

Local Excision of Clinical T3 Rectal Adenocarcinoma Showing Major Response(ycT0-1) After Neoadjuvant Chemoradiotherapy

Clinical trial NCT02490709 · UNKNOWN

Trial details

NCT number
NCT02490709
Sponsor
National Cancer Center, Korea
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Rectal Cancer
Start date
2015-04-01
Primary completion
2020-04-01
Enrollment
86

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.